4 results about "Regulation hormone" patented technology

A diabetes management system optimizes glucoregulatory hormone delivery using a connected glucoregulatory hormone delivery system and a computing device with a processor and non-transitory memory. The system receives glucose management data (glucose, insulin delivery, heart rate, or carbohydrate consumption data) from sensors. A digital twin metabolic model is selected and initialized based on the received data. The system simulates diabetes treatment interventions to predict glucose dynamics and determines an optimized glucoregulatory hormone parameter (e.g., insulin dose or increment that minimizes hyperglycemia and hypoglycemia risk). The determined glucoregulatory hormone parameter is transmitted to the connected glucoregulatory hormone delivery system, which may include an automated insulin delivery (AID) system or a connected insulin pen system, for implementation. By integrating real-time physiological data with predictive metabolic modeling, the system enhances glucoregulatory hormone therapy, providing personalized adjustments to improve glucose control.

Nutritional supplements and compositions for activating the GLP‑1 peptide and / or other hormones in a subject in order to regulate blood sugar, weight, and hunger of the subject are described in this application. The compositions include a first nutritional supplement containing specific amounts of hydrolyzed yeast, acacia gum powder, citrus bioflavonoids, cinnamon bark, and eggplant whole vegetable. The compositions also include a second nutritional supplement containing specific amounts of medium chain triglycerides, resistant potato starch, resistant tapioca starch, kombucha, guar gum, blueberry juice powder, cranberry fruit powder, and grape seed extract. A third composition includes the first and second nutritional supplements containing these ingredients in sufficient amounts to regulate the GLP‑1 hormone and / or other metabolic hormones. These compositions can increase the total GLP‑1 production up to about 220%. Other embodiments are also described.

The invention relates to the technical field of biological medicine, in particular to a novel application of a burdock-fructus forsythiae medicine pair and a medicine containing the burdock-fructus forsythiae medicine pair and used for adjusting the hormone level, and finds that the burdock-fructus forsythiae medicine pair can improve the hormone level of female mice and male rats for the first time. Tests finally find that when the mass ratio of the burdock alcohol extract to the fructus forsythiae alcohol extract is 1: 2, the hormone level adjusting effect is optimal, the inhibition effect of cyclophosphamide on splenic lymphocytes can be effectively relieved, meanwhile, the anti-inflammatory effect is optimal, and the pharmaceutical composition is suitable for clinical application. Therefore, the effect of treating the acne can be achieved by independently using the burdock alcohol extract and the fructus forsythiae alcohol extract, and the problems that a traditional Chinese medicine composition is complex in compatibility, high in medication cost, large in side effect and the like are solved.

Nutritional supplements and compositions for activating the GLP-1 peptide and / or other hormones in a subject in order to regulate blood sugar, weight, and hunger of the subject are described in this application. The compositions include a first nutritional supplement containing specific amounts of hydrolyzed yeast, acacia gum powder, citrus bioflavonoids, cinnamon bark, and eggplant whole vegetable. The compositions also include a second nutritional supplement containing specific amounts of medium chain triglycerides, resistant potato starch, resistant tapioca starch, kombucha, guar gum, blueberry juice powder, cranberry fruit powder, and grape seed extract. A third composition includes the first and second nutritional supplements containing these ingredients in sufficient amounts to regulate the GLP-1 hormone and / or other hormones. These compositions can increase the total GLP-1 production up to about 200%. Other embodiments are also described.